New developments in antiretroviral drug therapy for human immunodeficiency virus infections.
Johnson
V A
VA
Massachusetts General Hospital, Harvard Medical School, Boston.
Hirsch
M S
MS
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D015704:CD4 Antigens; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D007372:Interferons